ConductScience.org, home

Paper32927872

A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.

Paszkiewicz RL and 8 others. Int J Mol Sci, 2020. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided. Papers, record 32927872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32927872

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2024-02-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paszkiewicz RLRebecca L
2Bergman RNRichard N
3Santos RSRoberta Shttps://orcid.org/0000-0003-1652-3212
4Frank APAaron P
5Woolcott OOOrison Ohttps://orcid.org/0000-0003-2905-972X
6Iyer MSMalini Shttps://orcid.org/0000-0001-7776-7216
7Stefanovski DDarko
8Clegg DJDeborah Jhttps://orcid.org/0000-0003-3506-4402
9Kabir MMorvaridhttps://orcid.org/0000-0003-0880-3767

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdipocytesMajor topic
LipolysisMajor topic
MorpholinesMajor topic
Oxygen ConsumptionMajor topic
PyrazolesMajor topic
Receptor, Cannabinoid, CB1Major topic
3T3 Cells
Animals
Drug Evaluation, Preclinical
Mice
Mitochondria
Obesity

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK027619NIDDK NIH HHSUnited StatesR01DK027619PubMedNIH RePORTER
R01 DK029867NIDDK NIH HHSUnited StatesR01DK029867PubMedNIH RePORTER
R01-DK029867NIH HHSUnited StatesR01DK029867PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in33922401
Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020, 21, 6639.
https://conductscience.org/library/papers/33922401

Source PubMed

Download CSV of comments and corrections

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129158541Dysregulation of mitochondrial function and biogenesis modulators in adipose tissue of obese children.Int J Obes (Lond)2018https://conductscience.org/library/papers/29158541PubMed
230568302Thermal stress induces glycolytic beige fat formation via a myogenic state.Nature2019https://conductscience.org/library/papers/30568302PubMed
38371057Fat cell adrenergic receptors and the control of white and brown fat cell function.J Lipid Res1993https://conductscience.org/library/papers/8371057PubMed
430219068Localization of fat depots and cardiovascular risk.Lipids Health Dis2018https://conductscience.org/library/papers/30219068PubMed
519366874Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs.Am J Physiol Endocrinol Metab2009https://conductscience.org/library/papers/19366874PubMed
626390217Isoproterenol Increases Uncoupling, Glycolysis, and Markers of Beiging in Mature 3T3-L1 Adipocytes.PLoS One2015https://conductscience.org/library/papers/26390217PubMed
715855325Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo.Diabetes2005https://conductscience.org/library/papers/15855325PubMed
819578688The psychiatric side-effects of rimonabant.Braz J Psychiatry2009https://conductscience.org/library/papers/19578688PubMed
916009704The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.FASEB J2005https://conductscience.org/library/papers/16009704PubMed
1022728333β(1) Adrenergic receptor is key to cold- and diet-induced thermogenesis in mice.J Endocrinol2012https://conductscience.org/library/papers/22728333PubMed
1115836887Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.Lancet2005https://conductscience.org/library/papers/15836887PubMed
1215131120Role of insulin action and cell size on protein expression patterns in adipocytes.J Biol Chem2004https://conductscience.org/library/papers/15131120PubMed
1324809334Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.J Cell Physiol2014https://conductscience.org/library/papers/24809334PubMed
1427345961Sarcolipin knockout mice fed a high-fat diet exhibit altered indices of adipose tissue inflammation and remodeling.Obesity (Silver Spring)2016https://conductscience.org/library/papers/27345961PubMed
1531161155Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity.Nat Metab2019https://conductscience.org/library/papers/31161155PubMed
1619339685Transcriptional control of brown adipocyte development and physiological function--of mice and men.Genes Dev2009https://conductscience.org/library/papers/19339685PubMed
1729615900Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.Front Pharmacol2018https://conductscience.org/library/papers/29615900PubMed
1828704952The Inhibitory Effect of Tartary Buckwheat Extracts on Adipogenesis and Inflammatory Response.Molecules2017https://conductscience.org/library/papers/28704952PubMed
1917526015Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.Hepatology2007https://conductscience.org/library/papers/17526015PubMed
2020880401A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.Br J Pharmacol2010https://conductscience.org/library/papers/20880401PubMed

See all 51 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42559446Tissue-specific roles of monoacylglycerol (MAG) in metabolic diseases.Immunometabolism (Cobham)2026https://conductscience.org/library/papers/42559446PubMed
39512900The impact of cannabinoid receptor 1 absence on mouse liver mitochondria homeostasis: insight into mitochondrial unfolded protein response.Front Cell Dev Biol2024https://conductscience.org/library/papers/39512900PubMed
39273484
Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein-Cannabinoid Type 1 Receptor Double Knockout Animals.
Int J Mol Sci2024https://conductscience.org/library/papers/39273484PubMed
36767008Pharmacological Support for the Treatment of Obesity-Present and Future.Healthcare (Basel)2023https://conductscience.org/library/papers/36767008PubMed
35063024The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition.Stem Cell Res Ther2022https://conductscience.org/library/papers/35063024PubMed
34500853CB1 Cannabinoid Receptor Signaling and Biased Signaling.Molecules2021https://conductscience.org/library/papers/34500853PubMed
34434170Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34434170PubMed
33922401
Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020, 21, 6639.
Int J Mol Sci2021https://conductscience.org/library/papers/33922401PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32927872

GET https://conductscience.org/api/papers/v1/32927872/references?page=2